DRESS syndrome medical therapy

DRESS syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating DRESS syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
DRESS syndrome On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of DRESS syndrome All Images syndrome X-ray X-rays syndrome Ultrasound Echo & Ultrasound syndrome CT CT Images syndrome MRI MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on DRESS syndrome
CDC on DRESS syndrome
DRESS syndrome in the news
Blogs on DRESS syndrome
Directions to Hospitals Treating DRESS syndrome
Risk calculators and risk factors for DRESS syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Medical Therapy

• Drug withdrawal is the first step in the management of DRESS syndrome.
• Patients with severe skin eruptions are usually admitted to the hospital for close monitoring and fluid/electrolyte management.
• Supportive care is considered the mainstay of therapy, and administration of pharmacologic agents is usually necessary. Data from randomized clinical trials regarding the efficacy of immunosuppressive therapy in the management of DRESS syndrome is not yet available.
• Persistent DRESS syndrome often requires prolonged therapy.
• The following drugs have been used in the management of DRESS syndrome:

1. Symptomatic relief of pruritus

• Topical corticosteroids:

2. Liver involvement

• Unknown benefit of systemic corticosteroids
• Referral to liver transplant in cases of severe hepatic injury (> 3x ULN of LFTs)

3. Lung involvement

• Systemic corticosteroids: Prednisone 0.5-2 mg/kg/day (or equivalent) IV until clinical improvement THEN tapered slowly over 2-3 months

4. Renal involvement

• Systemic corticosteroids: Prednisone 0.5-2 mg/kg/day (or equivalent) IV until clinical improvement THEN tapered slowly over 2-3 months

Other Pharmacologic Agents

Other pharmacologic agents that have been used in DRESS syndrome are the following:

• Cyclosporin
• IV immunoglobulin